Zaditen 0,25 mg/ml Ögondroppar, lösning i endosbehållare

Ország: Svédország

Nyelv: svéd

Forrás: Läkemedelsverket (Medical Products Agency)

Betegtájékoztató Betegtájékoztató (PIL)
03-11-2020
Termékjellemzők Termékjellemzők (SPC)
28-10-2014

Aktív összetevők:

ketotifenvätefumarat

Beszerezhető a:

Medartuum AB

ATC-kód:

S01GX08

INN (nemzetközi neve):

ketotifen hydrogen fumarate

Adagolás:

0,25 mg/ml

Gyógyszerészeti forma:

Ögondroppar, lösning i endosbehållare

Összetétel:

glycerol Hjälpämne; ketotifenvätefumarat 0,345 mg Aktiv substans

Recept típusa:

Receptfritt

Termék összefoglaló:

Förpacknings: Endosbehållare, 60 x 0,4 ml (skyddspåse)

Engedélyezési státusz:

Avregistrerad

Engedély dátuma:

2019-03-27

Betegtájékoztató

                                For medicine without prescription
1
PACKAGE LEAFLET: INFORMATION FOR THE USER
ZADITEN 0.25 MG/ML, EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINERS
Ketotifen


<[To be completed nationally]>
WHAT IS IN THIS LEAFLET
:
1.
What Zaditen is and what it is used for
2.
What you need to know before you use Zaditen
3.
How to use Zaditen
4.
Possible side effects
5.
How to store Zaditen
6.
Contents of the pack and other information
1.
WHAT ZADITEN IS AND WHAT IT IS USED FOR
Zaditen contains the active substance ketotifen, which is an
anti-allergic substance. Zaditen is used to
treat eye symptoms of hay fever.
>
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE ZADITEN
DO NOT USE ZADITEN
If you are allergic to ketotifen or any of the other ingredients of
this medicine (listed in section 6).
_
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Termékjellemzők

                                1
1
NAME OF THE MEDICINAL PRODUCT
Zaditen 0.25 mg/ml
_,_
eye drops, solution in single-dose containers.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
0.4 ml contains 0.138 mg ketotifen fumarate corresponding to 0.1 mg
ketotifen.
Each drop contains 9.5 microgram ketotifen fumarate.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Eye drops, solution in single-dose containers.
Clear, colourless to faintly yellow solution.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Symptomatic treatment of seasonal allergic conjunctivitis.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults, elderly and children (age 3 and older): one drop of Zaditen
into the conjunctival sac twice a
day. The contents of a single-dose container are sufficient for one
administration into both eyes.
_Paediatric population_
The safety and efficacy of Zaditen in children below the age of 3
years have not yet been
established.
Method of administration
The contents remain sterile until the original closure is broken. To
avoid contamination do not touch
any surface with the tip of the container.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1.
4.4
SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
No special warning.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
If Zaditen is used concomitantly with other eye medications there must
be an interval of at least 5
minutes between the medications.
2
The use of oral dosage forms of ketotifen may potentiate the effects
of CNS depressants,
antihistamines and alcohol. Although this has not been observed with
Zaditen eye drops, the
possibility of such effects cannot be excluded.
4.6
FERTILITY, PREGNANCY AND LACTATION
Pregnancy
There are no adequate data from the use of ketotifen eye drops in
pregnant women.
_ _
Animal studies
using maternally toxic oral doses showed increased pre- and postnatal
mortality, but no teratogenicity.
Systemic levels after ocular administration are much lower than
                                
                                Olvassa el a teljes dokumentumot
                                
                            

Dokumentumok más nyelveken

Betegtájékoztató Betegtájékoztató angol 15-06-2023
Termékjellemzők Termékjellemzők angol 03-07-2020